Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 233
Selected: 0
NCT IDTitle
NCT02502721A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152
NCT02909270Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy
NCT04294251Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
NCT05304845Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
NCT02089399Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers
NCT07730138Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer
NCT04721535A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2
NCT04772443Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
NCT01945684A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
NCT06121830Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)
NCT01094847Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine
NCT05072938Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
NCT05376930Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.
NCT06025409Evaluate the Efficacy and Safety of DWJ108J
NCT03184402Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)
NCT04120753Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab
NCT05500898Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults
NCT07267221Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
NCT05389215Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
NCT02946450Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients
NCT04393597Effects of Food on the Pharmacokinetics of DWJ1458 in Healthy Adults
NCT05660135Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
NCT05672836ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
NCT03487562Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects
NCT04477369Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers
NCT05660122A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab
NCT02369302Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers
NCT05816681Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
NCT03753477Clinical Trial to Investigate the Efficacy and Safety of DWJ1351
NCT06627322A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
NCT04521296Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo
NCT07558707Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice
NCT04221399Type 2 Diabetes Patients With Renal Impairment
NCT01764295Clinical Study for Patients With Hypertension Associated With Dyslipidemia
NCT03947528Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions
NCT06682000Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
NCT07515599Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension
NCT03512821A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions
NCT04014023Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
NCT04278391Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers
NCT07479056Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy
NCT05410535To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
NCT06212960Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
NCT01634308Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation
NCT04343547Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults
NCT05643508A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
NCT04541485To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)
NCT02952755Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers
NCT03512808A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions
NCT02069717Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)